A citation-based method for searching scientific literature

Caleb R Glassman, Naotaka Tsutsumi, Robert A Saxton, Patrick J Lupardus, Kevin M Jude, K Christopher Garcia. Science 2022
Times Cited: 10







List of co-cited articles
55 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase.
Yibing Shan, Kavitha Gnanasambandan, Daniela Ungureanu, Eric T Kim, Henrik Hammarén, Kazuo Yamashita, Olli Silvennoinen, David E Shaw, Stevan R Hubbard. Nat Struct Mol Biol 2014
102
40

Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition.
Patrick J Lupardus, Mark Ultsch, Heidi Wallweber, Pawan Bir Kohli, Adam R Johnson, Charles Eigenbrot. Proc Natl Acad Sci U S A 2014
121
40

ATP binding to the pseudokinase domain of JAK2 is critical for pathogenic activation.
Henrik M Hammarén, Daniela Ungureanu, Jean Grisouard, Radek C Skoda, Stevan R Hubbard, Olli Silvennoinen. Proc Natl Acad Sci U S A 2015
66
40

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.
Chloé James, Valérie Ugo, Jean-Pierre Le Couédic, Judith Staerk, François Delhommeau, Catherine Lacout, Loïc Garçon, Hana Raslova, Roland Berger, Annelise Bennaceur-Griscelli,[...]. Nature 2005
30

Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F.
Rajintha M Bandaranayake, Daniela Ungureanu, Yibing Shan, David E Shaw, Olli Silvennoinen, Stevan R Hubbard. Nat Struct Mol Biol 2012
154
30

Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations.
Stephan Wilmes, Maximillian Hafer, Joni Vuorio, Julie A Tucker, Hauke Winkelmann, Sara Löchte, Tess A Stanly, Katiuska D Pulgar Prieto, Chetan Poojari, Vivek Sharma,[...]. Science 2020
55
30

Facile discovery of surrogate cytokine agonists.
Michelle Yen, Junming Ren, Qingxiang Liu, Caleb R Glassman, Timothy P Sheahan, Lora K Picton, Fernando R Moreira, Arjun Rustagi, Kevin M Jude, Xiang Zhao,[...]. Cell 2022
10
30

The protein kinase complement of the human genome.
G Manning, D B Whyte, R Martinez, T Hunter, S Sudarsanam. Science 2002
30

Kinase drug discovery 20 years after imatinib: progress and future directions.
Philip Cohen, Darren Cross, Pasi A Jänne. Nat Rev Drug Discov 2021
162
30

The regulation of JAKs in cytokine signaling and its breakdown in disease.
Henrik M Hammarén, Anniina T Virtanen, Juuli Raivola, Olli Silvennoinen. Cytokine 2019
90
30

JAK2 V617F constitutive activation requires JH2 residue F595: a pseudokinase domain target for specific inhibitors.
Alexandra Dusa, Céline Mouton, Christian Pecquet, Murielle Herman, Stefan N Constantinescu. PLoS One 2010
65
20

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.
Srdan Verstovsek, Ruben A Mesa, Jason Gotlib, Richard S Levy, Vikas Gupta, John F DiPersio, John V Catalano, Michael Deininger, Carole Miller, Richard T Silver,[...]. N Engl J Med 2012
20

The Tribbles 2 (TRB2) pseudokinase binds to ATP and autophosphorylates in a metal-independent manner.
Fiona P Bailey, Dominic P Byrne, Krishnadev Oruganty, Claire E Eyers, Christopher J Novotny, Kevan M Shokat, Natarajan Kannan, Patrick A Eyers. Biochem J 2015
56
20

The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling.
Daniela Ungureanu, Jinhua Wu, Tuija Pekkala, Yashavanthi Niranjan, Clifford Young, Ole N Jensen, Chong-Feng Xu, Thomas A Neubert, Radek C Skoda, Stevan R Hubbard,[...]. Nat Struct Mol Biol 2011
181
20

The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.
James M Murphy, Peter E Czabotar, Joanne M Hildebrand, Isabelle S Lucet, Jian-Guo Zhang, Silvia Alvarez-Diaz, Rowena Lewis, Najoua Lalaoui, Donald Metcalf, Andrew I Webb,[...]. Immunity 2013
720
20

The enzymatic phosphorylation of proteins.
G BURNETT, E P KENNEDY. J Biol Chem 1954
325
20

Tribbles in the 21st Century: The Evolving Roles of Tribbles Pseudokinases in Biology and Disease.
Patrick A Eyers, Karen Keeshan, Natarajan Kannan. Trends Cell Biol 2017
122
20


Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis.
Emma J Petrie, Jarrod J Sandow, Annette V Jacobsen, Brian J Smith, Michael D W Griffin, Isabelle S Lucet, Weiwen Dai, Samuel N Young, Maria C Tanzer, Ahmad Wardak,[...]. Nat Commun 2018
100
20

Structure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinases.
Angela V Toms, Anagha Deshpande, Randall McNally, Youngjee Jeong, Julia M Rogers, Chae Un Kim, Sol M Gruner, Scott B Ficarro, Jarrod A Marto, Martin Sattler,[...]. Nat Struct Mol Biol 2013
61
20

The pseudoactive site of ILK is essential for its binding to alpha-Parvin and localization to focal adhesions.
Koichi Fukuda, Sudhiranjan Gupta, Ka Chen, Chuanyue Wu, Jun Qin. Mol Cell 2009
137
20

An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.
Xuewu Zhang, Jodi Gureasko, Kui Shen, Philip A Cole, John Kuriyan. Cell 2006
20

Prospects for pharmacological targeting of pseudokinases.
Jennifer E Kung, Natalia Jura. Nat Rev Drug Discov 2019
62
20

Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3.
Natalia Jura, Yibing Shan, Xiaoxian Cao, David E Shaw, John Kuriyan. Proc Natl Acad Sci U S A 2009
235
20


A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties.
James M Murphy, Qingwei Zhang, Samuel N Young, Michael L Reese, Fiona P Bailey, Patrick A Eyers, Daniela Ungureanu, Henrik Hammaren, Olli Silvennoinen, Leila N Varghese,[...]. Biochem J 2014
194
20

Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1.
Sam A Jamieson, Zheng Ruan, Abigail E Burgess, Jack R Curry, Hamish D McMillan, Jodi L Brewster, Anita K Dunbier, Alison D Axtman, Natarajan Kannan, Peter D Mace. Sci Signal 2018
36
20



Molecular Mechanism of CCAAT-Enhancer Binding Protein Recruitment by the TRIB1 Pseudokinase.
James M Murphy, Yoshio Nakatani, Sam A Jamieson, Weiwen Dai, Isabelle S Lucet, Peter D Mace. Structure 2015
73
20

A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK.
Damian F Brennan, Arvin C Dar, Nicholas T Hertz, William C H Chao, Alma L Burlingame, Kevan M Shokat, David Barford. Nature 2011
187
20

Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.
Diego A Jaitin, Laila C Roisman, Eva Jaks, Martynas Gavutis, Jacob Piehler, Jose Van der Heyden, Gilles Uze, Gideon Schreiber. Mol Cell Biol 2006
171
20

A family of cytokine-inducible inhibitors of signalling.
R Starr, T A Willson, E M Viney, L J Murray, J R Rayner, B J Jenkins, T J Gonda, W S Alexander, D Metcalf, N A Nicola,[...]. Nature 1997
20

Structural linkage between ligand discrimination and receptor activation by type I interferons.
Christoph Thomas, Ignacio Moraga, Doron Levin, Peter O Krutzik, Yulia Podoplelova, Angelica Trejo, Choongho Lee, Ganit Yarden, Susan E Vleck, Jeffrey S Glenn,[...]. Cell 2011
243
20

Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling.
Stephan Wilmes, Oliver Beutel, Zhi Li, Véronique Francois-Newton, Christian P Richter, Dennis Janning, Cindy Kroll, Patrizia Hanhart, Katharina Hötte, Changjiang You,[...]. J Cell Biol 2015
73
20



The molecular regulation of Janus kinase (JAK) activation.
Jeffrey J Babon, Isabelle S Lucet, James M Murphy, Nicos A Nicola, Leila N Varghese. Biochem J 2014
167
20

Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA.
X Chen, U Vinkemeier, Y Zhao, D Jeruzalmi, J E Darnell, J Kuriyan. Cell 1998
532
20


CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling.
J Irie-Sasaki, T Sasaki, W Matsumoto, A Opavsky, M Cheng, G Welstead, E Griffiths, C Krawczyk, C D Richardson, K Aitken,[...]. Nature 2001
417
20

Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism.
Alexandr P Kornev, Nina M Haste, Susan S Taylor, Lynn F Ten Eyck. Proc Natl Acad Sci U S A 2006
502
20


Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia.
Yunchao Chang, Jaeki Min, Jamie A Jarusiewicz, Marisa Actis, Shanshan Yu-Chen Bradford, Anand Mayasundari, Lei Yang, Divyabharathi Chepyala, Lisa J Alcock, Kathryn G Roberts,[...]. Blood 2021
16
20

SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition.
Nadia J Kershaw, James M Murphy, Nicholas P D Liau, Leila N Varghese, Artem Laktyushin, Eden L Whitlock, Isabelle S Lucet, Nicos A Nicola, Jeffrey J Babon. Nat Struct Mol Biol 2013
182
20

Stats: transcriptional control and biological impact.
David E Levy, J E Darnell. Nat Rev Mol Cell Biol 2002
20

The molecular details of cytokine signaling via the JAK/STAT pathway.
Rhiannon Morris, Nadia J Kershaw, Jeffrey J Babon. Protein Sci 2018
233
20

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia.
V Lacronique, A Boureux, V D Valle, H Poirel, C T Quang, M Mauchauffé, C Berthou, M Lessard, R Berger, J Ghysdael,[...]. Science 1997
647
20

Regulation of the Jak2 tyrosine kinase by its pseudokinase domain.
P Saharinen, K Takaluoma, O Silvennoinen. Mol Cell Biol 2000
258
20



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.